| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
August 2024 - 114 Präparate |
|
| | FI | PI | | Latano-Vision SDU 50 μg/ml | 30 x 0.2 ml | 10.13 | 27.45 | 10% | | Augentropfen: Latanoprostum 50 µg/ml | OmniVision AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Latano-Vision SDU 50 μg/ml | 90 x 0.2 ml | 29.57 | 48.60 | 10% | | Augentropfen: Latanoprostum 50 µg/ml | OmniVision AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 10 mg | 30 | 13.03 | 30.55 | 10% | | Filmtabletten: Atorvastatinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 10 mg | 90 | 38.59 | 58.50 | 10% | | Filmtabletten: Atorvastatinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 10 mg | 100 | 42.88 | 62.90 | 10% | | Filmtabletten: Atorvastatinum 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 20 mg | 30 | 13.03 | 30.55 | 10% | | Filmtabletten: Atorvastatinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 20 mg | 90 | 38.59 | 58.50 | 10% | | Filmtabletten: Atorvastatinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 20 mg | 100 | 42.88 | 62.90 | 10% | | Filmtabletten: Atorvastatinum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 40 mg | 30 | 13.03 | 30.55 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 40 mg | 90 | 38.59 | 58.50 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 40 mg | 100 | 42.88 | 62.90 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 80 mg | 30 | 13.03 | 30.55 | 10% | | Filmtabletten: Atorvastatinum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 80 mg | 90 | 38.59 | 58.50 | 10% | | Filmtabletten: Atorvastatinum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Atorvastatin-Mepha 80 mg | 100 | 42.88 | 62.95 | 10% | | Filmtabletten: Atorvastatinum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ticagrelor NOBEL 60 mg | 56 | 20.48 | 38.70 | 10% | | Filmtabletten: Ticagrelorum 60 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ticagrelor NOBEL 60 mg | 3 x 56 | 61.43 | 83.20 | 10% | | Filmtabletten: Ticagrelorum 60 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ticagrelor NOBEL 90 mg | 56 | 23.70 | 42.20 | 10% | | Filmtabletten: Ticagrelorum 90 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ticagrelor NOBEL 90 mg | 98 | 41.47 | 61.55 | 10% | | Filmtabletten: Ticagrelorum 90 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ticagrelor NOBEL 90 mg | 3 x 56 | 71.10 | 93.75 | 10% | | Filmtabletten: Ticagrelorum 90 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 1 mg | 20 | 2.23 | 11.65 | 10% | | Tabletten: Lorazepamum 1 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 1 mg | 20 | 2.23 | 11.65 | 10% | | Tabletten: Lorazepamum 1 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 1 mg | 50 | 3.81 | 13.40 | 10% | | Tabletten: Lorazepamum 1 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 1 mg | 50 | 3.81 | 13.40 | 10% | | Tabletten: Lorazepamum 1 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 2.5 mg | 20 | 2.75 | 12.20 | 10% | | Tabletten: Lorazepamum 2.5 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Lorazepam axapharm 2.5 mg | 50 | 6.29 | 16.05 | 10% | | Tabletten: Lorazepamum 2.5 mg | axapharm ag | B / SL / SG | FB | | G |  |
L | | FI | PI | | Lorazepam Spirig HC 1 mg | 20 | 2.23 | 11.65 | 10% | | Tabletten: Lorazepamum 1 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Lorazepam Spirig HC 1 mg | 50 | 3.81 | 13.40 | 10% | | Tabletten: Lorazepamum 1 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Lorazepam Spirig HC 2.5 mg | 20 | 2.75 | 12.20 | 10% | | Tabletten: Lorazepamum 2.5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Lorazepam Spirig HC 2.5 mg | 50 | 6.29 | 16.05 | 10% | | Tabletten: Lorazepamum 2.5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Paclitaxel-Albumin Spirig HC 5 mg/ml | | 178.18 | 210.20 | 10% | | Pulver zur Herstellung einer Infusionsdispersion: Paclitaxelum 100 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat Sandoz 120 mg | 14 | 88.87 | 113.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat Sandoz 240 mg | 56 | 355.51 | 403.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat Sandoz 240 mg | 168 | 1066.55 | 1176.35 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat Viatris 120 mg | 14 | 88.87 | 113.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | | | Dimethylfumarat Viatris 240 mg | 56 | 355.51 | 403.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | | | Dimethylfumarat Viatris 240 mg | 168 | 1066.55 | 1176.35 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat-Mepha Teva 120 mg | 14 | 88.87 | 113.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat-Mepha Teva 240 mg | 56 | 355.51 | 403.05 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Dimethylfumarat-Mepha Teva 240 mg | 168 | 1066.55 | 1176.35 | 10% | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | I/B | Abrysvo | | 155.12 | 185.10 | 10% | | | Pfizer AG | B / SL | FB | | G |  |
L | | FI | PI | I/B | Comirnaty JN.1 0.042 mg | 10 | 702.46 | 770.65 | 10% | | | Pfizer AG | B / SL | FB | | G |  |
L | | FI | PI | | Ebglyss 250 mg/2 ml | 2 | 1916.93 | 2101.20 | 10% | | Injektionslösung in Fertigspritze: Lebrikizumabum 250mg / 2ml | Almirall AG | B / SL | FB | | G |  |
L | | FI | | | Ruxience 100 mg/10 ml | | 203.40 | 237.65 | 10% | | Infusionskonzentrat: Rituximabum 100mg / 10ml | Pfizer AG | A / SL | FB | | G |  |
L | | FI | | | Ruxience 500 mg/50 ml | | 1051.32 | 1159.80 | 10% | | Infusionskonzentrat: Rituximabum 500mg / 50ml | Pfizer AG | A / SL | FB | | G |  |
L | | FI | PI | | Fabhalta 200 mg | 56 | 24998.27 | 25956.05 | 10% | | Kapseln: Iptacopanum 200 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | FI | PI | | Fruzaqla 1 mg | 21 | 847.86 | 938.50 | 10% | | Kapseln: Fruquintinibum 1 mg | Takeda Pharma AG | A / SL | FB | | G |  |
L | | FI | | | Fruzaqla 5 mg | 21 | 3782.91 | 4130.55 | 10% | | Kapseln: Fruquintinibum 5 mg | Takeda Pharma AG | A / SL | FB | | G |  |
L | | FI | PI | | Ebglyss 250 mg/2 ml | 2 x 2 ml | 1916.93 | 2101.20 | 10% | | Injektionslösung in Fertigpen: Lebrikizumabum 250mg / 2ml | Almirall AG | B / SL | FB | | G |  |
L | | FI | | | TECENTRIQ subkutan 1875 mg/15ml | | 4370.35 | 4769.45 | 10% | | Injektionslösung zur subkutanen Anwendung: Atezolizumabum 1875mg / 15ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
| | FI | | I/B | Abrysvo | 5 | PA | PA | k.A. | | | Pfizer AG | B | FB | | G |  |
| | FI | | I/B | Abrysvo | 10 | PA | PA | k.A. | | | Pfizer AG | B | FB | | G |  |
| | FI | PI | I/B | Comirnaty JN.1 30 μg | 10 | PA | PA | k.A. | | | Pfizer AG | B | FB | | G |  |
| | FI | PI | I/B | Comirnaty JN.1 10 μg | 10 | PA | PA | k.A. | | | Pfizer AG | B | FB | | G |  |
| | FI | | | Tranexam Labatec 500 mg/5 mL | 5 | PA | PA | k.A. | | Injektionslösung: Acidum Tranexamicum 500mg / 5ml | Labatec Pharma SA | B | FB | | G |  |
| | FI | | | Tranexam Labatec 1000 mg/10 mL | 5 | PA | PA | k.A. | | Injektionslösung: Acidum Tranexamicum 1000mg / 10ml | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Ebglyss 250 mg/2 ml | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Lebrikizumabum 250mg / 2ml | Almirall AG | B | FB | | G |  |
| | FI | PI | | Mebucaïne Dolo Honig- Zitrone 8.75 mg | 16 | PA | PA | k.A. | | Lutschtabletten: Flurbiprofenum 8.75 mg | Spirig HealthCare AG | D | FB | | G |  |
| | FI | | | Dafalgan Dolo Junior | 150 ml | PA | PA | k.A. | | Sirup: Paracetamolum 30 mg/ml | UPSA Switzerland AG | D | FB | | G |  |
| | FI | PI | | Dimetindene Leman 1 mg/g | 30 g | PA | PA | k.A. | | Gel: Dimetindeni Maleas 1 mg | Leman SKL SA | D | FB | | G |  |
| | FI | PI | | Dimetindene Leman 1 mg/g | 50 g | PA | PA | k.A. | | Gel: Dimetindeni Maleas 1 mg | Leman SKL SA | D | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 250 mg | 30 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 250 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 500 mg | 20 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 500 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 500 mg | 100 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 500 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 500 mg | 200 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 500 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 1000 mg | 30 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 1000 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 1000 mg | 100 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 1000 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | | | | Levetiracetam-Neuraxpharm 1000 mg | 200 | PA | PA | k.A. | | Filmtabletten: Levetiracetamum 1000 mg | Neuraxpharm Switzerland AG | B | FB | | G |  |
| | FI | PI | | Ebglyss 250 mg/2 ml | 2 ml | PA | PA | k.A. | | Injektionslösung in Fertigpen: Lebrikizumabum 250mg / 2ml | Almirall AG | B | FB | | G |  |
| | FI | PI | | Entresto 6 mg/6 mg | 60 | PA | PA | k.A. | | filmüberzogenes Granulat: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B | FB | | G |  |
| | FI | PI | | Entresto 15 mg/16 mg | 60 | PA | PA | k.A. | | filmüberzogenes Granulat: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B | FB | | G |  |
| | FI | PI | | Xalkori 20 mg | 60 | PA | PA | k.A. | | filmüberzogenes Granulat zum Einnehmen: Crizotinibum 20 mg | Pfizer AG | A | FB | | G |  |
| | FI | | | Xalkori 50 mg | 60 | PA | PA | k.A. | | filmüberzogenes Granulat zum Einnehmen: Crizotinibum 50 mg | Pfizer AG | A | FB | | G |  |
| | FI | | | Xalkori 150 mg | 60 | PA | PA | k.A. | | filmüberzogenes Granulat zum Einnehmen: Crizotinibum 150 mg | Pfizer AG | A | FB | | G |  |
| | FI | PI | | Dimethylfumarat Accord 120 mg | 14 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Accord Healthcare AG | B | FB | | G |  |
| | FI | | | Dimethylfumarat Accord 240 mg | 56 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Accord Healthcare AG | B | FB | | G |  |
| | FI | | | Dimethylfumarat Accord 240 mg | 168 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Accord Healthcare AG | B | FB | | G |  |
| | FI | PI | | Zilbrysq 16,6 mg | 7 | PA | PA | k.A. | | solution pour injection en seringue pré-remplie: Zilucoplanum 16.6mg / 0.416ml | UCB-Pharma SA | A | FB | | G |  |
| | FI | | | Zilbrysq 32,4 mg | 7 | PA | PA | k.A. | | solution pour injection en seringue pré-remplie: Zilucoplanum 32.4mg / 0.81ml | UCB-Pharma SA | A | FB | | G |  |
| | FI | | | Zilbrysq 23 mg | 7 | PA | PA | k.A. | | solution pour injection en seringue pré-remplie: Zilucoplanum 23mg / 0.574ml | UCB-Pharma SA | A | FB | | G |  |
| | FI | PI | I/B | Comirnaty JN.1 0.042 mg | | PA | PA | k.A. | | | Pfizer AG | B | FB | | G |  |
| | | | | Sugammadex OrPha 200 mg/2 ml | 10 | PA | PA | k.A. | | | OrPha Swiss GmbH | B | FB | | G |  |
| | FI | | | Dafalgan Dolo Junior | 90 ml | PA | PA | k.A. | | Sirup: Paracetamolum 30 mg/ml | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Dafalgan Dolo Junior | 90 ml | PA | PA | k.A. | | Sirup: Paracetamolum 30 mg/ml | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Dafalgan Dolo Junior | 150 ml | PA | PA | k.A. | | Sirup: Paracetamolum 30 mg/ml | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Ruxience 100 mg/10 ml | 2 x 1 | PA | PA | k.A. | | Infusionskonzentrat: Rituximabum 100mg / 10ml | Pfizer AG | A | FB | | G |  |
| | FI | | | Viant | 5 | PA | PA | k.A. | | Lyophilisat: 13 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | FI | | | Viant | 10 | PA | PA | k.A. | | Lyophilisat: 13 Wirkstoffe | B. Braun Medical SA | B | FB | | G |  |
| | | | | Eltrombopag NOBEL 12.5 mg | 14 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 12.5 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | | | | Eltrombopag NOBEL 25 mg | 14 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 25 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | | | | Eltrombopag NOBEL 25 mg | 28 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 25 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | | | | Eltrombopag NOBEL 50 mg | 14 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 50 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | | | | Eltrombopag NOBEL 50 mg | 28 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 50 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | | | | Eltrombopag NOBEL 75 mg | 28 | PA | PA | k.A. | | Filmtabletten: Eltrombopagum 75 mg | NOBEL Pharma Schweiz AG | A | FB | | G |  |
| | FI | PI | CM | Hanarbe 20 mg | 14 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 20 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 20 mg | 28 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 20 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 20 mg | 98 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 20 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 40 mg | 14 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 40 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 40 mg | 28 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 40 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 40 mg | 98 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 40 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 80 mg | 14 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 80 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 80 mg | 28 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 80 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | CM | Hanarbe 80 mg | 98 | PA | PA | k.A. | | Tabletten: Azilsartanum Medoxomilum 80 mg | Hasten Biopharmaceutic (Switzerland) AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | 3 | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | 3 | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | FI | PI | | Nuvaring | 3 | PA | PA | k.A. | | Vaginalring mit Applikator Btl: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | B | FB | | G |  |
| | | | | Dimethylfumarat Sandoz eco 120 mg | 14 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Dimethylfumarat Sandoz eco 240 mg | 56 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Dimethylfumarat Sandoz eco 240 mg | 168 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Dimethylfumarat Spirig HC 120 mg | 14 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg | Spirig HealthCare AG | B | FB | | G |  |
| | | | | Dimethylfumarat Spirig HC 240 mg | 56 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Spirig HealthCare AG | B | FB | | G |  |
| | | | | Dimethylfumarat Spirig HC 240 mg | 168 | PA | PA | k.A. | | magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg | Spirig HealthCare AG | B | FB | | G |  |